9 Sep – 11 Sep 2026  |  Marina Bay Sands, Singapore

Thursday, 10 September 2026

2:00 pm – 4:10 pm

RehaCare Learning Hub, Hall B, Level 1

Advancing Healthy Living, Preventive Care, Rehabilitation, and Elder Care Across Asia

Partnership with

Unlocking Asia's Longevity Dividend

Asia is at the epicentre of one of the most profound demographic transformations in human history. The number of people aged 60 and above in Southeast Asia alone is expected to grow by 124% from 77.4 million in 2020 to 173.3 million by 2050, increasing their population share from 1 in 9 to 1 in 5 persons. By 2030, one in four people across Asia will be over the age of 60.

This demographic shift is not only reshaping healthcare systems but also redefining how societies approach healthy living across the lifespan- providing greater emphasis on prevention, wellness, active rehabilitation, proactive health management.

The seminar brings together market intelligence, clinical perspectives, medtech innovation, and investor insights to examine how healthcare stakeholders across Asia are responding to this longevity challenge. The session explores how healthy living strategies—including nutrition, lifestyle change enabling tools, digital health monitors, and early risk detection solutions, new age rehabilitation solutions, remote healthcare platforms, support improved quality of life, reduced onset of diseases and reduce risk of errors and failures in rehabilitation and delay functional decline. There is increasing demand for assured recovery/outcomes, community-centred models aging with dignity, independence, and better quality of life.

Co-located with the inaugural RehaCare Asia 2026 at Medical Fair Asia, this seminar provides decision-makers and innovators with the strategic framework, market data, and cross-sector perspectives needed to lead the next phase of Asia’s care economy.

Asia's Longevity Data

Key Highlights

Asia's Demographic Imperative

Market intelligence on the size, scale, and speed of the ageing transition across Southeast and East Asia, and what it means for preventive care, rehabilitation services, and elder care demand through 2033.

Preventive care as a strategic imperative

How Asia Pacific — representing 36.3% of the global preventive medicine market share in 2026 — is shifting from reactive treatment to proactive, outcomes-driven health management.

Engaging the Community for healthy living and aging in place

How AI, remote monitoring, wearable sensors, and community care platforms are enabling children and adults to live independently and support in healthy living and manage pain and support effective rehabilitation through platform sat home — reducing institutional burden and improving dignity of care.

Investor and medtech opportunity

The new age rehabilitation market is evolving from being focused on mobility to recovery. The solutions have evolved from standalone devices to digitally connected solution to offer real-time interventions driving investments and growth in the sector.

Policy and ecosystem enablement

How governments across Singapore, Japan, Indonesia, Vietnam, and Malaysia are building national frameworks for long-term care, community-based service delivery, and digital health integration to support ageing populations.

Provider and operator perspectives

How rehabilitation hospitals, elder care providers, home care operators, and community health networks are adapting care models to meet rising demand with constrained clinical workforces.

Healthy Living market

It’s a trillion-dollar market, with business opportunities ranging from at-home services, personalized activities, preventive health prognosis. The industry is evolving and has huge opportunities for investors, innovators and provides to drive transformation.

Agenda on 10 September 2026, Thursday

*This is a preliminary agenda and subject to changes

2:00 pm – 2:15 pm

Opening Keynote — Asia’s Longevity Dividend: Market Outlook for Healthy Living, Preventive Care, Rehabilitation, and Elder Care to 2033

Sets the strategic context for the seminar with a data-rich overview of Asia’s ageing demographic transformation and the market opportunities it is creating across three pillars — healthy living, preventive care, rehabilitation and aging in place. The metabolic diseases that impact quality of life from prime ages of life has been rising up to 1.7–3.7× over the past three decades. By 2030, one in four people across Asia will be over the age of 60. Thus, the burden of diseases doubles with a demographic challenge increasing focus on Asia’s Longevity Dividend: a generational opportunity for healthcare providers, technology companies, investors, and policymakers to co-create a more resilient, inclusive, and sustainable care economy.

▶ Speaker: 

Rathanesh Ramasundram

Head of Healthcare & Life Sciences (APAC, Growth Advisory), Frost & Sullivan

2:15 pm – 2:35 pm

The Rise of Healthy Living: Foundations, Urgency, and Future Opportunities

Explores emerging opportunities in healthy ageing and community-based care, focusing on senior co-living, assisted living and shared stay-in caregiving. The session will examine new residential care models, their intended caregiving and healthcare layers, and their potential to expand practical, dignified options for ageing in place.

▶ Speaker: 

Dr Eric Chiam Choon Guan

CEO and Founder of Minmed Group Pte Ltd and Minmed Homes Pte Ltd

2:35 pm – 2:55 pm

Panel Discussion 1 — Prevention, Rehabilitation & Ageing in Place and Living Fully: Bridging gaps through Community led Care

Examines two mutually reinforcing imperatives — investing in prevention to reduce the onset and burden of chronic disease and designing community-based care ecosystems that enable better rehabilitation and older adults to age in place with dignity and independence to live fully.

▶ Moderator: 

Rathanesh Ramasundram

Head of Healthcare & Life Sciences (APAC, Growth Advisory), Frost & Sullivan

▶ Panelists:

Dr Eric Chiam Choon Guan

CEO and Founder of Minmed Group Pte Ltd and Minmed Homes Pte Ltd

Adjunct Associate Professor Eugene Shum Jin Wen

Director, Strategic Community Partnership
SingHealth Office of Regional Health

2:55 pm – 3:15 pm

Innovative Applications of Digital Conservative Rehabilitation Technologies in Asia-Pacific: Musculoskeletal Conditions and Scoliosis Management as Case Studies

Explores how medtech and hospitals are disrupting the rehabilitation sector with digitally enabled services that assure outcomes and real-time support with AI-powered solutions, virtual and augmented reality therapy, platforms, motion sensors, data-driven personalized recovery pathways.

Speaker:

Olina Huang

Lead of Clinic Operations Management, Guangzhou Longjikang Technology Co., Ltd.

3:15 pm – 3:35 pm

Panel Discussion 2 — “Tech-Powered Recovery: Can MedTech Solve Asia’s Rehabilitation Access Gap?”

Explores the technology and clinical perspectives on the real-world barriers and enablers of rehabilitation technology adoption in Asia — examining the gap between innovation availability and equitable patient access across different healthcare systems and income levels.

Moderator: 

Rubyni Karun

Country Head, Singapore, Frost & Sullivan

▶ Panelists:

Navjeewan Khosla

Partner, Novo Holdings Asia

Olina Huang

Lead of Clinic Operations Management, Guangzhou Longjikang Technology Co., Ltd.

3:35 pm – 3:55 pm

Investing in Longevity: Capital, Policy, and the Business Case for Asia’s Care Economy

Makes the investment and strategic case for Asia’s care economy — examining where private capital is flowing, what business models are proving viable at scale, and how public policy is shaping the commercial opportunity across preventive, rehabilitative and elder care. Explores the investment landscape: which subsectors are attracting the most venture and PE capital (rehabilitation robotics, AI elder care, preventive diagnostics, community care platforms etc.).

Speaker:

Scott Montgomery

Group CEO, i-screen

3:55 pm – 4:10 pm

Closing Note: The Path Forward: Three Imperatives for Asia’s Care Leaders Remarks

 

The Frost & Sullivan keynote speaker closes the session with a concise, forward-looking synthesis of the seminar’s key insights — distilling the market intelligence, clinical evidence, technology perspectives, and investment signals into three clear imperatives for Asia’s care leaders:
Closes with a direct call to action for attendees to carry the seminar’s insights onto the RehaCare Asia exhibition floor — engaging with innovators, partners, and policymakers to turn market intelligence into meaningful action.

Speaker:

Rubyni Karun

Country Head, Singapore, Frost & Sullivan

Suggested Attendees

Designed for decision-makers, clinical leaders, technology innovators, investors, and public policy stakeholders involved in shaping, delivering, funding, and transforming preventive care, rehabilitation, and elder care across Southeast Asia and the broader Asia-Pacific region.

Hospital and Health System Leaders

Chief Medical Officer, Head of Rehabilitation, Director of Geriatrics, Head of Preventive and Community Medicine, Clinical Programme Director, Chief Nursing Officer.

Rehabilitation and Allied Health Professionals

Elder Care and Long-Term Care Operators

Medtech and Digital Health Innovators

Preventive Health & Wellness Providers

Investors and Strategy Stakeholders

Government and Regulatory Bodies

Academic and Research Institutions

Payers and Insurers

Regional Healthcare Ecosystem Stakeholders 

Scroll to Top

Rathanesh Ramasundram

Head of Healthcare & Life Sciences (APAC, Growth Advisory), Frost & Sullivan

Rathanesh Ramasundram is a healthcare strategist with over 20 years in the healthcare industry, including 16 years in growth and strategy consulting. She is passionate about crafting impactful strategies that accelerate organizational success and transformation. Rathanesh specializes in supporting organizations expand their market presence across APAC and globally, with deep expertise in business growth roadmaps, go-to-market strategies, benchmarking, competitive and customer intelligence, and pipeline optimization.

Dr Eric Chiam Choon Guan

CEO and Founder of Minmed Group Pte Ltd and Minmed Homes Pte Ltd

Dr Eric Chiam is a Singapore physician-entrepreneur, founder and chief executive with 25 years of experience building and transforming regulated, multi-site healthcare services. He established his first primary-care clinic in 2001 and now leads Minmed Group, an integrated healthcare platform spanning more than 30 clinics, health screening and diagnostics, paediatrics, dentistry, counselling, fitness and wellness, telemedicine, home care and hospital-at-home.

Adjunct Associate Professor Eugene Shum Jin Wen

Director, Strategic Community Partnership
SingHealth Office of Regional Health

Dr Eugene Shum is Director, Strategic Community Partnership at the SingHealth Office of Regional Health. He is also Senior Population and Public Health Consultant, Changi General Hospital and Senior Research Scientist, Centre for Population Health Research and Implementation. Through partnerships with community organisations, he has developed pioneering health-social initiatives such as the Neighbours for Active Living programme and CareLine, a 24/7 nationwide telecare service. These initiatives received the Ministry of Health National Clinical Excellence Team Awards in 2024 and 2022 respectively. Dr Shum has special interests in urban health and the built environment. He was previously Chief Corporate Development Officer at Eastern Health Alliance and Director, Medical Affairs and Innovation at Khoo Teck Puat Hospital. He has held various portfolios at the Ministry of Health, Singapore.

Olina Huang

Lead of Clinic Operations Management, Guangzhou Longjikang Technology Co., Ltd.

Olina Huang, Lead of Clinic Operations Management, possesses extensive experience in developing and refining clinical workflows for chain healthcare groups across China. She is currently in charge of digital operations and daily clinic operations modules at Longjikang Clinics.

Rubyni Karun

Country Head, Singapore, Frost & Sullivan

Rubyni Karun is a business strategist, and speaker specializing in leadership, innovation, and human capital transformation. With more than two decades of advisory and growth consulting experience, she works with multinational corporations, healthcare organizations, investors and public sector stakeholders across Asia-Pacific to drive future-ready transformation. As a senior leader at Frost & Sullivan , Rubyni brings a unique perspective on how technology, workforce transformation, and leadership intersect to create sustainable impact. At RehaCare Asia 2026, she will facilitate discussions on rehabilitation innovation and share strategic insights on the opportunities and imperatives shaping Asia’s longevity and care economy.

Corinna Schröder

Director Events and Marketing, Wearable Technologies

Corinna manages events and marketing at Wearable Technologies AG, bringing her skills in marketing, events, and research to the role.

She completed her Master’s degree in Business Administration and Economics (MSc) in January 2023. Corinna started at Wearable Technologies in February 2023 as a Project Manager for Marketing and Events, quickly demonstrating her abilities.

Before joining Wearable Technologies, Corinna gained valuable experience through internships and student positions, including international jobs at Blum-Novotest K.K. in Japan and Yamazaki Mazak Europe in the UK.

Corinna’s educational background and diverse work experiences make her a strong asset in the fast-paced world of events and marketing.

Scott Montgomery

Group CEO, i-screen

Scott Montgomery is the Group CEO of i-screen, a preventive health technology platform operating across Australia, Singapore, New Zealand, and the United Kingdom. Under his leadership, i-screen has grown to serve over 145,000 users and delivered more than 1.1 million diagnostic tests, building one of the most comprehensive longitudinal multi-omic datasets in the Asia-Pacific region, spanning blood biomarkers, genomics, microbiome, and metabolomics.

Scott leads i-screen’s evolution from a direct-to-consumer testing business into an AI-powered health intelligence platform, integrating wearable data, digital vitals, and continuous glucose monitoring with traditional pathology to deliver personalised, preventive health insights at scale. His work sits at the intersection of clinical diagnostics, artificial intelligence, and consumer health technology.

Based in Singapore, Scott oversees i-screen’s expansion across four regulated markets and its partnerships with major wearable technology companies, practitioner networks spanning 4,000+ providers in Southeast Asia, and laboratory partners including the Eurofins network. He is passionate about shifting healthcare from reactive treatment to predictive prevention, using multi-omic data and AI to give individuals earlier, more actionable insight into their health trajectory.